Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	regulation of establishment of planar polarity involved in neural tube closure	VANGL2 DVL3 DVL1	6.24e-07	15	24	3	GO:0090178
GeneOntologyBiologicalProcess	establishment of planar polarity involved in neural tube closure	VANGL2 DVL3 DVL1	7.67e-07	16	24	3	GO:0090177
GeneOntologyBiologicalProcess	establishment of planar polarity of embryonic epithelium	VANGL2 DVL3 DVL1	1.12e-06	18	24	3	GO:0042249
GeneOntologyBiologicalProcess	regulation of establishment of planar polarity	VANGL2 DVL3 DVL1	1.32e-06	19	24	3	GO:0090175
GeneOntologyBiologicalProcess	outflow tract morphogenesis	VANGL2 DVL3 BMP4 DVL1	4.01e-06	94	24	4	GO:0003151
GeneOntologyBiologicalProcess	outflow tract septum morphogenesis	VANGL2 DVL3 BMP4	4.45e-06	28	24	3	GO:0003148
GeneOntologyBiologicalProcess	cochlea morphogenesis	VANGL2 DVL3 DVL1	4.96e-06	29	24	3	GO:0090103
GeneOntologyBiologicalProcess	regulation of animal organ morphogenesis	VANGL2 DVL3 BMP4 DVL1	7.49e-06	110	24	4	GO:2000027
GeneOntologyBiologicalProcess	neural plate elongation	VANGL2 DVL1	7.77e-06	4	24	2	GO:0014022
GeneOntologyBiologicalProcess	convergent extension involved in neural plate elongation	VANGL2 DVL1	7.77e-06	4	24	2	GO:0022007
GeneOntologyBiologicalProcess	neural tube closure	VANGL2 DVL3 BMP4 DVL1	8.34e-06	113	24	4	GO:0001843
GeneOntologyBiologicalProcess	tube closure	VANGL2 DVL3 BMP4 DVL1	8.64e-06	114	24	4	GO:0060606
GeneOntologyBiologicalProcess	primary neural tube formation	VANGL2 DVL3 BMP4 DVL1	1.06e-05	120	24	4	GO:0014020
GeneOntologyBiologicalProcess	neural tube formation	VANGL2 DVL3 BMP4 DVL1	1.64e-05	134	24	4	GO:0001841
GeneOntologyBiologicalProcess	establishment of planar polarity	VANGL2 DVL3 DVL1	1.78e-05	44	24	3	GO:0001736
GeneOntologyBiologicalProcess	establishment of tissue polarity	VANGL2 DVL3 DVL1	1.90e-05	45	24	3	GO:0007164
GeneOntologyBiologicalProcess	muscular septum morphogenesis	VANGL2 BMP4	1.94e-05	6	24	2	GO:0003150
GeneOntologyBiologicalProcess	convergent extension involved in organogenesis	VANGL2 DVL1	2.72e-05	7	24	2	GO:0060029
GeneOntologyBiologicalProcess	heart morphogenesis	VANGL2 DVL3 BMP4 KAT6A DVL1	2.95e-05	321	24	5	GO:0003007
GeneOntologyBiologicalProcess	embryonic epithelial tube formation	VANGL2 DVL3 BMP4 DVL1	3.20e-05	159	24	4	GO:0001838
GeneOntologyBiologicalProcess	Wnt signaling pathway, planar cell polarity pathway	VANGL2 DVL3 DVL1	3.49e-05	55	24	3	GO:0060071
GeneOntologyBiologicalProcess	positive regulation of neuron projection arborization	DVL3 DVL1	3.62e-05	8	24	2	GO:0150012
GeneOntologyBiologicalProcess	epithelial tube formation	VANGL2 DVL3 BMP4 DVL1	4.46e-05	173	24	4	GO:0072175
GeneOntologyBiologicalProcess	neural plate morphogenesis	VANGL2 DVL1	4.65e-05	9	24	2	GO:0001839
GeneOntologyBiologicalProcess	cochlea development	VANGL2 DVL3 DVL1	4.77e-05	61	24	3	GO:0090102
GeneOntologyBiologicalProcess	membranous septum morphogenesis	VANGL2 BMP4	5.81e-05	10	24	2	GO:0003149
GeneOntologyBiologicalProcess	tube formation	VANGL2 DVL3 BMP4 DVL1	6.03e-05	187	24	4	GO:0035148
GeneOntologyBiologicalProcess	morphogenesis of embryonic epithelium	VANGL2 DVL3 BMP4 DVL1	6.42e-05	190	24	4	GO:0016331
GeneOntologyBiologicalProcess	convergent extension involved in gastrulation	VANGL2 DVL1	7.09e-05	11	24	2	GO:0060027
GeneOntologyBiologicalProcess	neural tube development	VANGL2 DVL3 BMP4 DVL1	8.14e-05	202	24	4	GO:0021915
GeneOntologyBiologicalProcess	morphogenesis of a polarized epithelium	VANGL2 DVL3 DVL1	8.16e-05	73	24	3	GO:0001738
GeneOntologyBiologicalProcess	non-canonical Wnt signaling pathway	VANGL2 DVL3 DVL1	9.57e-05	77	24	3	GO:0035567
GeneOntologyBiologicalProcess	lateral sprouting from an epithelium	VANGL2 BMP4	1.00e-04	13	24	2	GO:0060601
GeneOntologyBiologicalProcess	neural plate development	VANGL2 DVL1	1.17e-04	14	24	2	GO:0001840
GeneOntologyBiologicalProcess	regulation of neuron projection arborization	DVL3 DVL1	1.35e-04	15	24	2	GO:0150011
GeneOntologyBiologicalProcess	cardiac septum morphogenesis	VANGL2 DVL3 BMP4	1.47e-04	89	24	3	GO:0060411
GeneOntologyBiologicalProcess	inner ear development	VANGL2 DVL3 BMP4 DVL1	1.94e-04	253	24	4	GO:0048839
GeneOntologyBiologicalProcess	spliceosomal complex assembly	RSRP1 LUC7L2 RBMX2	2.02e-04	99	24	3	GO:0000245
GeneOntologyBiologicalProcess	convergent extension	VANGL2 DVL1	2.19e-04	19	24	2	GO:0060026
GeneOntologyBiologicalProcess	ear development	VANGL2 DVL3 BMP4 DVL1	3.05e-04	285	24	4	GO:0043583
GeneOntologyBiologicalProcess	developmental growth involved in morphogenesis	VANGL2 BMP4 DRAXIN DVL1	3.66e-04	299	24	4	GO:0060560
GeneOntologyBiologicalProcess	mRNA processing	RSRP1 PNN SCAF8 LUC7L2 RBMX2	3.73e-04	551	24	5	GO:0006397
GeneOntologyBiologicalProcess	embryonic organ development	VANGL2 DVL3 BMP4 KAT6A DVL1	4.05e-04	561	24	5	GO:0048568
GeneOntologyBiologicalProcess	inner ear morphogenesis	VANGL2 DVL3 DVL1	4.39e-04	129	24	3	GO:0042472
GeneOntologyBiologicalProcess	cardiac septum development	VANGL2 DVL3 BMP4	4.91e-04	134	24	3	GO:0003279
GeneOntologyBiologicalProcess	sensory organ morphogenesis	VANGL2 DVL3 BMP4 DVL1	6.14e-04	343	24	4	GO:0090596
GeneOntologyBiologicalProcess	embryonic organ morphogenesis	VANGL2 DVL3 BMP4 DVL1	6.69e-04	351	24	4	GO:0048562
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	RSRP1 PNN LUC7L2 RBMX2	7.20e-04	358	24	4	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	RSRP1 PNN LUC7L2 RBMX2	7.20e-04	358	24	4	GO:0000377
GeneOntologyBiologicalProcess	ear morphogenesis	VANGL2 DVL3 DVL1	7.36e-04	154	24	3	GO:0042471
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	RSRP1 PNN LUC7L2 RBMX2	7.51e-04	362	24	4	GO:0000375
GeneOntologyBiologicalProcess	cardiac chamber morphogenesis	VANGL2 DVL3 BMP4	8.38e-04	161	24	3	GO:0003206
GeneOntologyBiologicalProcess	neuron projection arborization	DVL3 DVL1	8.89e-04	38	24	2	GO:0140058
GeneOntologyBiologicalProcess	axis elongation	VANGL2 BMP4	8.89e-04	38	24	2	GO:0003401
GeneOntologyBiologicalProcess	epithelial tube branching involved in lung morphogenesis	VANGL2 BMP4	1.03e-03	41	24	2	GO:0060441
GeneOntologyBiologicalProcess	regulation of vascular endothelial growth factor receptor signaling pathway	BMP4 MYOF	1.19e-03	44	24	2	GO:0030947
GeneOntologyBiologicalProcess	epithelial tube morphogenesis	VANGL2 DVL3 BMP4 DVL1	1.32e-03	421	24	4	GO:0060562
GeneOntologyBiologicalProcess	heart development	VANGL2 DVL3 BMP4 KAT6A DVL1	1.56e-03	757	24	5	GO:0007507
GeneOntologyBiologicalProcess	cardiac chamber development	VANGL2 DVL3 BMP4	1.85e-03	212	24	3	GO:0003205
GeneOntologyBiologicalProcess	gastrulation	VANGL2 BMP4 DVL1	1.85e-03	212	24	3	GO:0007369
GeneOntologyBiologicalProcess	ventricular septum morphogenesis	VANGL2 BMP4	1.92e-03	56	24	2	GO:0060412
GeneOntologyBiologicalProcess	neuron projection morphogenesis	VANGL2 DVL3 RERE DRAXIN DVL1	2.01e-03	802	24	5	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	VANGL2 DVL3 RERE DRAXIN DVL1	2.21e-03	819	24	5	GO:0120039
GeneOntologyBiologicalProcess	endocrine pancreas development	BMP4 ZNF800	2.28e-03	61	24	2	GO:0031018
GeneOntologyBiologicalProcess	cell projection morphogenesis	VANGL2 DVL3 RERE DRAXIN DVL1	2.29e-03	826	24	5	GO:0048858
GeneOntologyBiologicalProcess	RNA splicing	RSRP1 PNN LUC7L2 RBMX2	2.50e-03	502	24	4	GO:0008380
GeneOntologyBiologicalProcess	protein-RNA complex assembly	RSRP1 LUC7L2 RBMX2	2.75e-03	244	24	3	GO:0022618
GeneOntologyBiologicalProcess	Wnt signaling pathway	VANGL2 DVL3 DRAXIN DVL1	2.76e-03	516	24	4	GO:0016055
GeneOntologyBiologicalProcess	vascular endothelial growth factor receptor signaling pathway	BMP4 MYOF	2.90e-03	69	24	2	GO:0048010
GeneOntologyBiologicalProcess	neuron projection development	VANGL2 DVL3 BMP4 RERE DRAXIN DVL1	2.94e-03	1285	24	6	GO:0031175
GeneOntologyBiologicalProcess	protein-RNA complex organization	RSRP1 LUC7L2 RBMX2	3.08e-03	254	24	3	GO:0071826
GeneOntologyBiologicalProcess	morphogenesis of a branching structure	VANGL2 BMP4 RERE	3.22e-03	258	24	3	GO:0001763
GeneOntologyBiologicalProcess	heart looping	VANGL2 DVL1	3.24e-03	73	24	2	GO:0001947
GeneOntologyBiologicalProcess	morphogenesis of an epithelial sheet	VANGL2 DVL1	3.33e-03	74	24	2	GO:0002011
GeneOntologyCellularComponent	Wnt signalosome	DVL3 DVL1	1.63e-04	16	25	2	GO:1990909
HumanPheno	Finger syndactyly	DVL3 BMP4 RERE KAT6A DVL1	6.91e-06	218	8	5	HP:0006101
HumanPheno	Cleft lip	VANGL2 DVL3 BMP4 RERE DVL1	1.11e-05	240	8	5	HP:0410030
HumanPheno	Abnormal phalangeal joint morphology of the hand	DVL3 BMP4 RERE KAT6A DVL1	1.71e-05	262	8	5	HP:0006261
HumanPheno	Short hard palate	BMP4 DVL1	2.15e-05	5	8	2	HP:0010290
HumanPheno	Anterior bulging of the globe	VANGL2 DVL3 BMP4 KAT6A DVL1	2.49e-05	283	8	5	HP:0000644
HumanPheno	Proptosis	VANGL2 DVL3 BMP4 KAT6A DVL1	2.49e-05	283	8	5	HP:0000520
HumanPheno	Midface retrusion	DVL3 BMP4 RERE KAT6A DVL1	2.86e-05	291	8	5	HP:0011800
HumanPheno	Naevus flammeus of the eyelid	DVL3 DVL1	4.52e-05	7	8	2	HP:0010733
HumanPheno	Euryblepharon	DVL3 DVL1	7.73e-05	9	8	2	HP:0012905
HumanPheno	Ridged fingernail	DVL3 DVL1	7.73e-05	9	8	2	HP:0008402
HumanPheno	Onychogryposis of fingernail	DVL3 DVL1	7.73e-05	9	8	2	HP:0040036
HumanPheno	Open bite	DVL3 BMP4 DVL1	8.77e-05	61	8	3	HP:0010807
HumanPheno	Craniofacial cleft	VANGL2 DVL3 BMP4 RERE KAT6A DVL1	1.37e-04	694	8	6	HP:5201015
HumanPheno	Orofacial cleft	VANGL2 DVL3 BMP4 RERE KAT6A DVL1	1.37e-04	694	8	6	HP:0000202
HumanPheno	Syndactyly	DVL3 BMP4 RERE KAT6A DVL1	1.63e-04	417	8	5	HP:0001159
HumanPheno	Abnormal shape of the frontal region	VANGL2 DVL3 BMP4 RERE KAT6A DVL1	2.00e-04	741	8	6	HP:0011218
HumanPheno	Abnormal frontal bone morphology	VANGL2 DVL3 BMP4 RERE KAT6A DVL1	2.02e-04	742	8	6	HP:0430000
HumanPheno	Abnormality of the epiphysis of the femoral head	DVL3 BMP4 DVL1	2.20e-04	83	8	3	HP:0010574
HumanPheno	Curly eyelashes	DVL3 DVL1	2.24e-04	15	8	2	HP:0007665
HumanPheno	Low-set ears	VANGL2 DVL3 BMP4 RERE KAT6A DVL1	2.33e-04	761	8	6	HP:0000369
HumanPheno	Abnormal femoral epiphysis morphology	DVL3 BMP4 DVL1	2.45e-04	86	8	3	HP:0006499
HumanPheno	Fingernail dysplasia	DVL3 DVL1	2.56e-04	16	8	2	HP:0100798
HumanPheno	Broad thumb	DVL3 RERE DVL1	2.80e-04	90	8	3	HP:0011304
HumanPheno	Flexion contracture of finger	DVL3 BMP4 RERE DVL1	2.90e-04	240	8	4	HP:0005651
HumanPheno	Camptodactyly (hands)	DVL3 BMP4 RERE DVL1	2.90e-04	240	8	4	HP:0010563
HumanPheno	Camptodactyly of toe	DVL3 BMP4 RERE DVL1	2.90e-04	240	8	4	HP:0001836
HumanPheno	Joint contractures involving the joints of the feet	DVL3 BMP4 RERE DVL1	2.90e-04	240	8	4	HP:0100492
HumanPheno	Camptodactyly of finger	DVL3 BMP4 RERE DVL1	2.90e-04	240	8	4	HP:0100490
HumanPheno	Flexion contracture of toe	DVL3 BMP4 RERE DVL1	2.90e-04	240	8	4	HP:0005830
HumanPheno	Interphalangeal joint contracture of finger	DVL3 BMP4 RERE DVL1	2.90e-04	240	8	4	HP:0001220
HumanPheno	Posteriorly rotated ears	DVL3 BMP4 RERE KAT6A DVL1	2.90e-04	470	8	5	HP:0000358
HumanPheno	Toe joint contracture	DVL3 BMP4 RERE DVL1	2.94e-04	241	8	4	HP:0034675
HumanPheno	Abnormal femoral head morphology	DVL3 BMP4 DVL1	2.99e-04	92	8	3	HP:0003368
HumanPheno	Abnormal lower limb epiphysis morphology	DVL3 BMP4 DVL1	3.19e-04	94	8	3	HP:0006500
HumanPheno	Abnormal lip morphology	VANGL2 DVL3 BMP4 MYOF RERE KAT6A DVL1	3.31e-04	1249	8	7	HP:0000159
HumanPheno	Anodontia	DVL3 DVL1	3.64e-04	19	8	2	HP:0000674
HumanPheno	Flexion contracture of finger	DVL3 BMP4 RERE DVL1	3.77e-04	257	8	4	HP:0012785
HumanPheno	Finger joint contracture	DVL3 BMP4 RERE DVL1	3.89e-04	259	8	4	HP:0034681
HumanPheno	Femoral hernia	DVL3 DVL1	4.04e-04	20	8	2	HP:0100541
HumanPheno	Triangular mouth	DVL3 DVL1	4.04e-04	20	8	2	HP:0000207
HumanPheno	Abnormal nail morphology	DVL3 BMP4 MYOF RERE DVL1	4.52e-04	516	8	5	HP:0001597
HumanPheno	Joint contractures	DVL3 BMP4 RERE DVL1	6.16e-04	292	8	4	HP:0001372
HumanPheno	Bifid tongue	DVL3 DVL1	6.36e-04	25	8	2	HP:0010297
HumanPheno	Joint contracture of the hand	DVL3 BMP4 RERE DVL1	6.49e-04	296	8	4	HP:0009473
HumanPheno	Anteverted nares	DVL3 BMP4 RERE KAT6A DVL1	6.60e-04	559	8	5	HP:0000463
HumanPheno	Upturned nose	DVL3 BMP4 RERE KAT6A DVL1	6.60e-04	559	8	5	HP:0000427
HumanPheno	Peg-shaped maxillary lateral incisors	BMP4 KAT6A	6.88e-04	26	8	2	HP:0006342
HumanPheno	Short phalanx of finger	DVL3 BMP4 RERE DVL1	7.37e-04	306	8	4	HP:0009803
HumanPheno	Abnormal nostril morphology	DVL3 BMP4 RERE KAT6A DVL1	7.54e-04	575	8	5	HP:0005288
HumanPheno	Abnormal location of ears	VANGL2 DVL3 BMP4 RERE KAT6A DVL1	7.99e-04	945	8	6	HP:0000357
HumanPheno	Epispadias	DVL3 DVL1	8.58e-04	29	8	2	HP:0000039
HumanPheno	Onychogryposis	DVL3 DVL1	8.58e-04	29	8	2	HP:0001805
HumanPheno	Aplasia/Hypoplasia of the phalanges of the hand	DVL3 BMP4 RERE DVL1	8.64e-04	319	8	4	HP:0009767
HumanPheno	Avascular necrosis of the capital femoral epiphysis	DVL3 DVL1	9.19e-04	30	8	2	HP:0005743
HumanPheno	Abnormal earlobe morphology	BMP4 RERE KAT6A	9.65e-04	137	8	3	HP:0000363
HumanPheno	Abnormal limb epiphysis morphology	DVL3 BMP4 DVL1	9.86e-04	138	8	3	HP:0006505
HumanPheno	Depressed nasal bridge	VANGL2 DVL3 BMP4 RERE DVL1	1.01e-03	612	8	5	HP:0005280
HumanPheno	Flattened nasal bridge	VANGL2 DVL3 BMP4 RERE DVL1	1.01e-03	612	8	5	HP:0000425
HumanPheno	Epicanthus	DVL3 BMP4 RERE KAT6A DVL1	1.03e-03	614	8	5	HP:0000286
HumanPheno	Foot joint contracture	DVL3 BMP4 RERE DVL1	1.03e-03	334	8	4	HP:0008366
HumanPheno	Abnormality of the tubular bones	DVL3 BMP4 RERE KAT6A DVL1	1.17e-03	632	8	5	HP:0100713
HumanPheno	Abnormality of the long tubular bones	DVL3 BMP4 RERE KAT6A DVL1	1.17e-03	632	8	5	HP:0100714
HumanPheno	Camptodactyly	DVL3 BMP4 RERE DVL1	1.18e-03	346	8	4	HP:0012385
HumanPheno	Clitoral hypoplasia	DVL3 DVL1	1.18e-03	34	8	2	HP:0000060
HumanPheno	Aplasia/Hypoplasia of the clitoris	DVL3 DVL1	1.18e-03	34	8	2	HP:0040255
HumanPheno	Ridged nail	DVL3 DVL1	1.18e-03	34	8	2	HP:0001807
HumanPheno	Foot polydactyly	BMP4 RERE DVL1	1.19e-03	147	8	3	HP:0001829
HumanPheno	Duplication involving bones of the feet	BMP4 RERE DVL1	1.19e-03	147	8	3	HP:0009136
HumanPheno	Broad phalanx	DVL3 RERE DVL1	1.21e-03	148	8	3	HP:0006009
HumanPheno	Broad phalanges of the hand	DVL3 RERE DVL1	1.21e-03	148	8	3	HP:0009768
HumanPheno	Abnormal morphology of the nasal alae	DVL3 BMP4 RERE KAT6A DVL1	1.24e-03	639	8	5	HP:0000429
HumanPheno	Hypoplastic labia minora	DVL3 DVL1	1.25e-03	35	8	2	HP:0000064
HumanPheno	Abnormal number of permanent teeth	DVL3 BMP4	1.25e-03	35	8	2	HP:0011044
HumanPheno	Mesomelia	DVL3 DVL1	1.25e-03	35	8	2	HP:0003027
HumanPheno	Abnormal nasal bridge morphology	VANGL2 DVL3 BMP4 RERE KAT6A DVL1	1.29e-03	1029	8	6	HP:0000422
HumanPheno	Adrenal hypoplasia	VANGL2 BMP4	1.32e-03	36	8	2	HP:0000835
HumanPheno	Broad finger	DVL3 RERE DVL1	1.36e-03	154	8	3	HP:0001500
HumanPheno	Upper-limb joint contracture	DVL3 BMP4 RERE DVL1	1.40e-03	362	8	4	HP:0100360
HumanPheno	Flexion contracture of digit	DVL3 BMP4 RERE DVL1	1.40e-03	362	8	4	HP:0030044
HumanPheno	Hypoplastic labia majora	DVL3 DVL1	1.40e-03	37	8	2	HP:0000059
HumanPheno	Dental malocclusion	DVL3 BMP4 DVL1	1.41e-03	156	8	3	HP:0000689
HumanPheno	Tooth agenesis	DVL3 BMP4 KAT6A DVL1	1.41e-03	363	8	4	HP:0009804
HumanPheno	Broad long bones	DVL3 RERE DVL1	1.44e-03	157	8	3	HP:0005622
HumanPheno	Agenesis of incisor	BMP4 KAT6A	1.48e-03	38	8	2	HP:0006485
HumanPheno	Brachydactyly	DVL3 BMP4 RERE KAT6A DVL1	1.54e-03	670	8	5	HP:0001156
HumanPheno	Abnormal female external genitalia morphology	DVL3 RERE DVL1	1.54e-03	161	8	3	HP:0000055
HumanPheno	Capillary hemangioma	DVL3 DVL1	1.55e-03	39	8	2	HP:0005306
HumanPheno	Conical incisor	BMP4 KAT6A	1.55e-03	39	8	2	HP:0011065
HumanPheno	Short digit	DVL3 BMP4 RERE KAT6A DVL1	1.56e-03	672	8	5	HP:0011927
HumanPheno	Retrognathia	DVL3 BMP4 KAT6A DVL1	1.59e-03	375	8	4	HP:0000278
HumanPheno	Abnormal nail surface	DVL3 DVL1	1.63e-03	40	8	2	HP:0025757
HumanPheno	Abnormal labia minora morphology	DVL3 DVL1	1.72e-03	41	8	2	HP:0012880
HumanPheno	Abnormal tongue morphology	DVL3 BMP4 RERE DVL1	1.78e-03	386	8	4	HP:0030809
HumanPheno	Abnormal antihelix morphology	RERE KAT6A	1.89e-03	43	8	2	HP:0009738
HumanPheno	Juvenile aseptic necrosis	DVL3 DVL1	1.89e-03	43	8	2	HP:0100323
HumanPheno	Spinal canal stenosis	BMP4 RERE	1.89e-03	43	8	2	HP:0003416
HumanPheno	Abnormal midface morphology	DVL3 BMP4 RERE KAT6A DVL1	1.94e-03	704	8	5	HP:0000309
HumanPheno	Pectus carinatum	DVL3 BMP4 DVL1	2.06e-03	178	8	3	HP:0000768
HumanPheno	Abnormal labia majora morphology	DVL3 DVL1	2.07e-03	45	8	2	HP:0012881
MousePheno	abnormal heart and great artery attachment	VANGL2 DVL3 RERE PNN KAT6A	4.74e-06	205	18	5	MP:0010426
MousePheno	abnormal heart and great vessel attachment	VANGL2 DVL3 RERE PNN KAT6A	5.09e-06	208	18	5	MP:0010425
MousePheno	abnormal heart septum morphology	VANGL2 DVL3 BMP4 RERE PNN KAT6A	6.15e-06	388	18	6	MP:0006113
MousePheno	ventricular septal defect	VANGL2 BMP4 RERE PNN KAT6A	1.53e-05	261	18	5	MP:0010402
MousePheno	abnormal right subclavian artery morphology	VANGL2 RERE KAT6A	1.72e-05	40	18	3	MP:0010487
MousePheno	abnormal xiphoid process morphology	VANGL2 DVL3 BMP4	2.46e-05	45	18	3	MP:0000159
MousePheno	transposition of great arteries	RERE PNN KAT6A	2.81e-05	47	18	3	MP:0004110
MousePheno	double outlet right ventricle	VANGL2 DVL3 RERE PNN	3.47e-05	150	18	4	MP:0000284
MousePheno	abnormal subclavian artery morphology	VANGL2 RERE KAT6A	4.76e-05	56	18	3	MP:0003395
MousePheno	abnormal interventricular septum morphology	VANGL2 BMP4 RERE PNN KAT6A	5.61e-05	342	18	5	MP:0000281
MousePheno	abnormal truncus arteriosus septation	VANGL2 DVL3 PNN	1.60e-04	84	18	3	MP:0010454
MousePheno	split xiphoid process	DVL3 BMP4	1.86e-04	16	18	2	MP:0004678
MousePheno	abnormal thoracic cage morphology	VANGL2 DVL3 BMP4 PNN KAT6A	2.34e-04	463	18	5	MP:0004624
MousePheno	abnormal left subclavian artery morphology	VANGL2 RERE	2.37e-04	18	18	2	MP:0010488
MousePheno	abnormal ventral body wall morphology	VANGL2 BMP4	3.24e-04	21	18	2	MP:0003384
MousePheno	abnormal cardiovascular development	VANGL2 DVL3 BMP4 RERE PNN KAT6A	3.58e-04	802	18	6	MP:0002925
MousePheno	cleft palate	VANGL2 RERE PNN KAT6A	4.35e-04	289	18	4	MP:0000111
MousePheno	oral cleft	VANGL2 RERE PNN KAT6A	4.47e-04	291	18	4	MP:0021164
MousePheno	abnormal aortic arch morphology	VANGL2 RERE KAT6A	4.47e-04	119	18	3	MP:0004113
MousePheno	abnormal cardiac outflow tract development	VANGL2 DVL3 PNN	6.33e-04	134	18	3	MP:0006126
MousePheno	abnormal thoracic aorta morphology	VANGL2 RERE KAT6A	6.33e-04	134	18	3	MP:0010468
MousePheno	abnormal heart looping	VANGL2 BMP4 RERE	6.46e-04	135	18	3	MP:0000269
MousePheno	abnormal palate morphology	VANGL2 RERE PNN KAT6A	6.47e-04	321	18	4	MP:0003755
MousePheno	lethality during fetal growth through weaning, complete penetrance	VANGL2 DVL3 BMP4 ZNF800 RERE PNN KAT6A	6.48e-04	1269	18	7	MP:0011111
MousePheno	abnormal facial morphology	VANGL2 DVL3 BMP4 RERE PNN KAT6A	7.05e-04	910	18	6	MP:0003743
MousePheno	small snout	VANGL2 DVL3 RERE	7.80e-04	144	18	3	MP:0030190
MousePheno	aberrant origin of the right subclavian artery	VANGL2 KAT6A	8.08e-04	33	18	2	MP:0010465
MousePheno	abnormal orientation of cochlear hair cell stereociliary bundles	VANGL2 DVL3	9.09e-04	35	18	2	MP:0004522
MousePheno	abnormal somite size	VANGL2 RERE	9.61e-04	36	18	2	MP:0005222
MousePheno	abnormal aortic arch and aortic arch branch attachment	VANGL2 KAT6A	1.02e-03	37	18	2	MP:0010464
MousePheno	perinatal lethality, complete penetrance	VANGL2 BMP4 RERE PNN KAT6A	1.66e-03	712	18	5	MP:0011089
MousePheno	abnormal vestibular hair cell morphology	VANGL2 BMP4	1.71e-03	48	18	2	MP:0002623
MousePheno	abnormal primitive streak morphology	VANGL2 BMP4 PNN	2.04e-03	201	18	3	MP:0002231
MousePheno	omphalocele	VANGL2 BMP4	2.08e-03	53	18	2	MP:0003052
MousePheno	abnormal artery morphology	VANGL2 BMP4 RERE KAT6A	2.09e-03	440	18	4	MP:0002191
MousePheno	abnormal head morphology	VANGL2 DVL3 BMP4 RERE PNN KAT6A	2.09e-03	1120	18	6	MP:0000432
MousePheno	abnormal somite shape	VANGL2 RERE	2.23e-03	55	18	2	MP:0001691
MousePheno	abnormal organ of Corti morphology	VANGL2 DVL3 BMP4	2.28e-03	209	18	3	MP:0000042
MousePheno	decreased rib number	VANGL2 BMP4	2.40e-03	57	18	2	MP:0003345
MousePheno	abnormal hair cell morphology	VANGL2 DVL3 BMP4	2.44e-03	214	18	3	MP:0000045
MousePheno	abnormal semicircular canal morphology	VANGL2 BMP4	2.57e-03	59	18	2	MP:0002428
MousePheno	right aortic arch	VANGL2 RERE	2.65e-03	60	18	2	MP:0004158
MousePheno	abnormal heart ventricle morphology	VANGL2 BMP4 RERE PNN KAT6A	2.67e-03	793	18	5	MP:0005294
MousePheno	abnormal midbrain development	VANGL2 BMP4	2.74e-03	61	18	2	MP:0003864
MousePheno	single kidney	BMP4 RERE	2.74e-03	61	18	2	MP:0003604
MousePheno	abnormal forebrain development	VANGL2 BMP4 RERE	2.81e-03	225	18	3	MP:0003232
MousePheno	abnormal presacral vertebrae morphology	BMP4 PNN KAT6A	2.81e-03	225	18	3	MP:0000459
MousePheno	abnormal aorta morphology	VANGL2 RERE KAT6A	2.81e-03	225	18	3	MP:0000272
MousePheno	abnormal inner ear canal morphology	VANGL2 BMP4	2.92e-03	63	18	2	MP:0002729
MousePheno	abnormal mechanoreceptor morphology	VANGL2 DVL3 BMP4	3.03e-03	231	18	3	MP:0000972
MousePheno	abnormal gland development	BMP4 ZNF800 KAT6A	3.10e-03	233	18	3	MP:0020973
MousePheno	abnormal ear development	VANGL2 BMP4	3.10e-03	65	18	2	MP:0003938
MousePheno	abnormal cochlear labyrinth morphology	VANGL2 DVL3 BMP4	3.18e-03	235	18	3	MP:0004426
MousePheno	abnormal scala media morphology	VANGL2 DVL3 BMP4	3.18e-03	235	18	3	MP:0003169
MousePheno	persistent truncus arteriosus	DVL3 PNN	3.30e-03	67	18	2	MP:0002633
MousePheno	abnormal aorticopulmonary septum morphology	DVL3 PNN	3.39e-03	68	18	2	MP:0010650
MousePheno	aorticopulmonary septal defect	DVL3 PNN	3.39e-03	68	18	2	MP:0010651
MousePheno	micrognathia	DVL3 KAT6A	3.39e-03	68	18	2	MP:0002639
MousePheno	abnormal digestive system morphology	VANGL2 BMP4 ZNF800 RERE PNN KAT6A	3.41e-03	1233	18	6	MP:0000462
MousePheno	abnormal cochlea morphology	VANGL2 DVL3 BMP4	3.70e-03	248	18	3	MP:0000031
MousePheno	limbs/digits/tail phenotype	VANGL2 BMP4 ST6GAL2 MYOF SNAPC4 KAT6A	3.78e-03	1258	18	6	MP:0005371
MousePheno	abnormal sternum morphology	VANGL2 DVL3 BMP4	4.00e-03	255	18	3	MP:0000157
MousePheno	abnormal rib morphology	VANGL2 BMP4 PNN	4.09e-03	257	18	3	MP:0000150
MousePheno	abnormal snout morphology	VANGL2 DVL3 RERE	4.09e-03	257	18	3	MP:0000443
MousePheno	abnormal digestive system development	VANGL2 BMP4	4.11e-03	75	18	2	MP:0003119
MousePheno	abnormal membranous labyrinth morphology	VANGL2 DVL3 BMP4	4.31e-03	262	18	3	MP:0000035
MousePheno	rib fusion	VANGL2 PNN	4.44e-03	78	18	2	MP:0000154
MousePheno	abnormal appendicular skeleton morphology	VANGL2 DVL3 BMP4 ST6GAL2 SNAPC4	4.54e-03	896	18	5	MP:0009250
MousePheno	abnormal vertebrae morphology	VANGL2 BMP4 PNN KAT6A	4.55e-03	546	18	4	MP:0000137
MousePheno	abnormal inner ear vestibule morphology	VANGL2 BMP4	4.78e-03	81	18	2	MP:0000034
MousePheno	abnormal abdominal wall morphology	VANGL2 BMP4	4.89e-03	82	18	2	MP:0003257
MousePheno	atrioventricular septal defect	BMP4 KAT6A	5.13e-03	84	18	2	MP:0010412
Domain	Dishevelled_protein_dom	DVL3 DVL1P1 DVL1	7.45e-09	4	24	3	IPR003351
Domain	Dishevelled	DVL3 DVL1P1 DVL1	7.45e-09	4	24	3	PF02377
Domain	Dishevelled_fam	DVL3 DVL1P1 DVL1	7.45e-09	4	24	3	IPR008339
Domain	DIX	DVL3 DVL1P1 DVL1	6.50e-08	7	24	3	IPR001158
Domain	DIX	DVL3 DVL1P1 DVL1	6.50e-08	7	24	3	PS50841
Domain	DAX	DVL3 DVL1P1 DVL1	6.50e-08	7	24	3	SM00021
Domain	DIX	DVL3 DVL1P1 DVL1	6.50e-08	7	24	3	PF00778
Domain	DVL-1	DVL1P1 DVL1	1.58e-06	2	24	2	IPR008340
Domain	DEP	DVL3 DVL1P1 DVL1	2.83e-06	22	24	3	SM00049
Domain	DEP	DVL3 DVL1P1 DVL1	2.83e-06	22	24	3	PF00610
Domain	DEP	DVL3 DVL1P1 DVL1	2.83e-06	22	24	3	PS50186
Domain	DEP_dom	DVL3 DVL1P1 DVL1	3.25e-06	23	24	3	IPR000591
Domain	Dsh_C	DVL3 DVL1	4.74e-06	3	24	2	PF12316
Domain	Dishevelled_C-dom	DVL3 DVL1	4.74e-06	3	24	2	IPR024580
Domain	Dsh/Dvl-rel	DVL3 DVL1	9.48e-06	4	24	2	IPR015506
Domain	PDZ	DVL3 DVL1P1 PDZD4 DVL1	2.94e-05	141	24	4	PF00595
Domain	PDZ	DVL3 DVL1P1 PDZD4 DVL1	3.56e-05	148	24	4	SM00228
Domain	PDZ	DVL3 DVL1P1 PDZD4 DVL1	3.85e-05	151	24	4	PS50106
Domain	PDZ	DVL3 DVL1P1 PDZD4 DVL1	3.95e-05	152	24	4	IPR001478
Domain	WHTH_DNA-bd_dom	DVL3 DVL1P1 KAT6A DVL1	2.38e-04	242	24	4	IPR011991
Domain	-	DVL3 PDZD4 DVL1	9.08e-04	150	24	3	2.30.42.10
Domain	Myb_DNA-binding	RERE SNAPC4	9.18e-04	35	24	2	PF00249
Domain	MYB_LIKE	RERE SNAPC4	1.08e-03	38	24	2	PS50090
Domain	SANT	RERE SNAPC4	1.87e-03	50	24	2	SM00717
Domain	SANT/Myb	RERE SNAPC4	2.02e-03	52	24	2	IPR001005
Domain	-	DVL3 KAT6A DVL1	2.65e-03	218	24	3	1.10.10.10
Domain	PHD	KAT6A RSF1	4.15e-03	75	24	2	PF00628
Domain	Znf_PHD-finger	KAT6A RSF1	4.59e-03	79	24	2	IPR019787
Domain	PHD	KAT6A RSF1	5.79e-03	89	24	2	SM00249
Domain	Znf_PHD	KAT6A RSF1	6.04e-03	91	24	2	IPR001965
Domain	ZF_PHD_2	KAT6A RSF1	6.57e-03	95	24	2	PS50016
Domain	ZF_PHD_1	KAT6A RSF1	6.70e-03	96	24	2	PS01359
Domain	Znf_FYVE_PHD	KAT6A RSF1	1.52e-02	147	24	2	IPR011011
Pathway	REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS	DVL3 DVL1	1.21e-05	5	16	2	M27447
Pathway	KEGG_BASAL_CELL_CARCINOMA	DVL3 BMP4 DVL1	3.04e-05	55	16	3	M17807
Pathway	REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL	DVL3 DVL1	3.37e-05	8	16	2	M27100
Pathway	REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL	DVL3 DVL1	4.33e-05	9	16	2	MM14792
Pathway	REACTOME_KILLING_MECHANISMS	DVL3 DVL1	7.92e-05	12	16	2	M29844
Pathway	REACTOME_PCP_CE_PATHWAY	VANGL2 DVL3 DVL1	1.42e-04	92	16	3	M27322
Pathway	KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY	DVL3 DVL1	1.44e-04	16	16	2	M47823
Pathway	WP_NEURAL_CREST_DIFFERENTIATION	DVL3 BMP4 DVL1	1.66e-04	97	16	3	MM15926
Pathway	PID_BETA_CATENIN_DEG_PATHWAY	DVL3 DVL1	1.83e-04	18	16	2	M31
Pathway	WP_NEURAL_CREST_DIFFERENTIATION	DVL3 BMP4 DVL1	1.87e-04	101	16	3	M39448
Pathway	PID_WNT_CANONICAL_PATHWAY	DVL3 DVL1	2.27e-04	20	16	2	M90
Pathway	WP_WNT_SIGNALING_PATHWAY	VANGL2 DVL3 DVL1	2.40e-04	110	16	3	MM15977
Pathway	WP_WNT_SIGNALING_WP428	VANGL2 DVL3 DVL1	2.60e-04	113	16	3	M39669
Pathway	WP_ESC_PLURIPOTENCY_PATHWAYS	DVL3 BMP4 DVL1	2.81e-04	116	16	3	MM15863
Pathway	WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS	DVL3 BMP4 DVL1	2.88e-04	117	16	3	M39530
Pathway	REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE	DVL3 DVL1	5.51e-04	31	16	2	M27400
Pathway	REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE	DVL3 DVL1	5.51e-04	31	16	2	MM15154
Pathway	REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING	VANGL2 DVL3 DVL1	5.52e-04	146	16	3	M27288
Pathway	PID_WNT_NONCANONICAL_PATHWAY	DVL3 DVL1	5.87e-04	32	16	2	M23
Pathway	KEGG_WNT_SIGNALING_PATHWAY	VANGL2 DVL3 DVL1	6.09e-04	151	16	3	M19428
Pathway	WP_WNT_SIGNALING_IN_KIDNEY_DISEASE	DVL3 DVL1	7.44e-04	36	16	2	M39699
Pathway	KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY	DVL3 DVL1	7.86e-04	37	16	2	M47411
Pathway	BIOCARTA_ALK_PATHWAY	BMP4 DVL1	7.86e-04	37	16	2	M17400
Pathway	WP_WNT_SIGNALING_IN_KIDNEY_DISEASE	DVL3 DVL1	1.11e-03	44	16	2	MM15878
Pathway	KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY	DVL3 DVL1	1.16e-03	45	16	2	M47412
Pathway	WP_NOTCH_SIGNALING_WP268	DVL3 DVL1	1.16e-03	45	16	2	M39571
Pathway	KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY	DVL3 DVL1	1.21e-03	46	16	2	M47409
Pathway	WP_NOTCH_SIGNALING_PATHWAY	DVL3 DVL1	1.21e-03	46	16	2	MM15971
Pathway	KEGG_NOTCH_SIGNALING_PATHWAY	DVL3 DVL1	1.27e-03	47	16	2	M7946
Pathway	WP_WNT_SIGNALING_WP363	DVL3 DVL1	1.49e-03	51	16	2	M39721
Pathway	REACTOME_DEGRADATION_OF_DVL	DVL3 DVL1	1.73e-03	55	16	2	MM15153
Pathway	REACTOME_DEGRADATION_OF_DVL	DVL3 DVL1	1.86e-03	57	16	2	M27399
Pathway	WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM	VANGL2 BMP4	2.06e-03	60	16	2	M40048
Pathway	WP_WNT_SIGNALING	DVL3 DVL1	2.13e-03	61	16	2	MM15893
Pathway	WP_JOUBERT_SYNDROME	DVL3 DVL1	3.28e-03	76	16	2	M39835
Pathway	REACTOME_PCP_CE_PATHWAY	DVL3 DVL1	4.08e-03	85	16	2	MM15041
Pathway	WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY	DVL3 DVL1	4.08e-03	85	16	2	M48315
Pathway	WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA	DVL3 DVL1	4.47e-03	89	16	2	M39563
Pathway	WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER	DVL3 DVL1	5.39e-03	98	16	2	M39731
Pathway	KEGG_PATHWAYS_IN_CANCER	DVL3 BMP4 DVL1	5.44e-03	325	16	3	M12868
Pathway	REACTOME_SIGNALING_BY_WNT	VANGL2 DVL3 DVL1	5.68e-03	330	16	3	M7847
Pathway	WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY	DVL3 DVL1	5.71e-03	101	16	2	MM15829
Pathway	KEGG_MELANOGENESIS	DVL3 DVL1	5.71e-03	101	16	2	M7761
Pathway	WP_WNT_SIGNALING_AND_PLURIPOTENCY	DVL3 DVL1	5.71e-03	101	16	2	M39387
Pathway	WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT	DVL3 DVL1	6.74e-03	110	16	2	M39492
Pathway	REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING	DVL3 DVL1	8.37e-03	123	16	2	MM14988
Pathway	WP_ADIPOGENESIS	BMP4 DVL1	9.44e-03	131	16	2	M39505
Pathway	WP_ADIPOGENESIS_GENES	BMP4 DVL1	1.03e-02	137	16	2	MM15970
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_FORMINS	DVL3 DVL1	1.07e-02	140	16	2	M27550
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_FORMINS	DVL3 DVL1	1.09e-02	141	16	2	MM15266
Pathway	WP_BREAST_CANCER_PATHWAY	DVL3 DVL1	1.29e-02	154	16	2	M39739
Pathway	WP_MRNA_PROCESSING	RSRC2 SCAF8 RBMX2	1.34e-02	451	16	3	MM15946
Pathway	REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT	DVL3 DVL1	1.35e-02	158	16	2	MM14791
Pubmed	cDNA characterization and chromosomal mapping of two human homologues of the Drosophila dishevelled polarity gene.	DVL3 DVL1P1 DVL1	1.48e-09	4	26	3	8817329
Pubmed	Human dishevelled genes constitute a DHR-containing multigene family.	DVL3 DVL1P1 DVL1	1.48e-09	4	26	3	9192851
Pubmed	Independent mutations in mouse Vangl2 that cause neural tube defects in looptail mice impair interaction with members of the Dishevelled family.	VANGL2 DVL3 DVL1	3.70e-09	5	26	3	15456783
Pubmed	Murine dishevelled 3 functions in redundant pathways with dishevelled 1 and 2 in normal cardiac outflow tract, cochlea, and neural tube development.	VANGL2 DVL3 DVL1	1.30e-08	7	26	3	19008950
Pubmed	Expression of planar cell polarity genes during development of the mouse CNS.	VANGL2 DVL3 DVL1	3.11e-08	9	26	3	16487141
Pubmed	Vangl2 acts via RhoA signaling to regulate polarized cell movements during development of the proximal outflow tract.	VANGL2 DVL3 DVL1	4.43e-08	10	26	3	15637299
Pubmed	Microtubules enable the planar cell polarity of airway cilia.	VANGL2 DVL3 DVL1	8.12e-08	12	26	3	23122850
Pubmed	The mouse Wnt/PCP protein Vangl2 is necessary for migration of facial branchiomotor neurons, and functions independently of Dishevelled.	VANGL2 DVL3 DVL1	2.06e-07	16	26	3	22771245
Pubmed	Posterior malformations in Dact1 mutant mice arise through misregulated Vangl2 at the primitive streak.	VANGL2 DVL3 DVL1	3.00e-07	18	26	3	19701191
Pubmed	Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction.	VANGL2 DVL1	5.37e-07	2	26	2	12490194
Pubmed	cDNA cloning of a human dishevelled DVL-3 gene, mapping to 3q27, and expression in human breast and colon carcinomas.	DVL3 DVL1	5.37e-07	2	26	2	9344861
Pubmed	Human homologue sequences to the Drosophila dishevelled segment-polarity gene are deleted in the DiGeorge syndrome.	DVL1P1 DVL1	5.37e-07	2	26	2	8644734
Pubmed	DVL3 Alleles Resulting in a -1 Frameshift of the Last Exon Mediate Autosomal-Dominant Robinow Syndrome.	DVL3 DVL1	5.37e-07	2	26	2	26924530
Pubmed	DVL1 and DVL3 require nuclear localisation to regulate proliferation in human myoblasts.	DVL3 DVL1	5.37e-07	2	26	2	35589804
Pubmed	Expression of dishevelled gene in Hirschsprung's disease.	DVL3 DVL1	5.37e-07	2	26	2	24040443
Pubmed	Atmin mediates kidney morphogenesis by modulating Wnt signaling.	VANGL2 DVL3 DVL1	7.43e-07	24	26	3	24852369
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	VANGL2 DVL3 PNN PDZD4 DVL1	1.38e-06	263	26	5	34702444
Pubmed	Wdpcp, a PCP protein required for ciliogenesis, regulates directional cell migration and cell polarity by direct modulation of the actin cytoskeleton.	VANGL2 DVL3 DVL1	1.49e-06	30	26	3	24302887
Pubmed	Dishevelled-3 C-terminal His single amino acid repeats are obligate for Wnt5a activation of non-canonical signaling.	DVL3 DVL1	1.61e-06	3	26	2	21092292
Pubmed	Purified Wnt-5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation.	DVL3 DVL1	1.61e-06	3	26	2	15748172
Pubmed	Differential mediation of the Wnt canonical pathway by mammalian Dishevelleds-1, -2, and -3.	DVL3 DVL1	1.61e-06	3	26	2	18093802
Pubmed	Genomic organization of mouse Dishevelled genes.	DVL3 DVL1	1.61e-06	3	26	2	8973355
Pubmed	Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression.	DVL3 DVL1	1.61e-06	3	26	2	18692936
Pubmed	DVL mutations identified from human neural tube defects and Dandy-Walker malformation obstruct the Wnt signaling pathway.	DVL3 DVL1	1.61e-06	3	26	2	32900645
Pubmed	Regulation of polarized extension and planar cell polarity in the cochlea by the vertebrate PCP pathway.	VANGL2 DVL1	1.61e-06	3	26	2	16116426
Pubmed	Essential role of the Dishevelled DEP domain in a Wnt-dependent human-cell-based complementation assay.	DVL3 DVL1	1.61e-06	3	26	2	27744318
Pubmed	Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia.	DVL3 DVL1	1.61e-06	3	26	2	27086035
Pubmed	Cytosolic TMEM88 promotes invasion and metastasis in lung cancer cells by binding DVLS.	DVL3 DVL1	1.61e-06	3	26	2	26359454
Pubmed	Dishevelled proteins are associated with olfactory sensory neuron presynaptic terminals.	DVL3 DVL1	1.61e-06	3	26	2	23437169
Pubmed	Autosomal Dominant Robinow Syndrome	DVL3 DVL1	1.61e-06	3	26	2	25577943
Pubmed	Planar cell polarity controls pancreatic beta cell differentiation and glucose homeostasis.	VANGL2 DVL3 DVL1	1.81e-06	32	26	3	23177622
Pubmed	SLMAP3 is essential for neurulation through mechanisms involving cytoskeletal elements, ABP, and PCP.	VANGL2 DVL3 DVL1	2.39e-06	35	26	3	39366759
Pubmed	Dual regulation of planar polarization by secreted Wnts and Vangl2 in the developing mouse cochlea.	VANGL2 DVL3 DVL1	2.39e-06	35	26	3	32907846
Pubmed	Huwe1-mediated ubiquitylation of dishevelled defines a negative feedback loop in the Wnt signaling pathway.	DVL3 DVL1	3.22e-06	4	26	2	24643799
Pubmed	DCDC2 mutations cause a renal-hepatic ciliopathy by disrupting Wnt signaling.	DVL3 DVL1	3.22e-06	4	26	2	25557784
Pubmed	Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein.	DVL3 DVL1	3.22e-06	4	26	2	11113207
Pubmed	Activation of p53 by Dishevelled independent of Wnt or planar polarity pathways.	DVL3 DVL1	3.22e-06	4	26	2	17593335
Pubmed	Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination.	VANGL2 DVL1	3.22e-06	4	26	2	28481871
Pubmed	Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways.	DVL3 DVL1	3.22e-06	4	26	2	19625296
Pubmed	Non-canonical Wnt signaling induces ubiquitination and degradation of Syndecan4.	DVL1P1 DVL1	3.22e-06	4	26	2	20639201
Pubmed	Dishevelled genes mediate a conserved mammalian PCP pathway to regulate convergent extension during neurulation.	VANGL2 DVL1	3.22e-06	4	26	2	16571627
Pubmed	Clinical and molecular characterization of four patients with Robinow syndrome from different families.	DVL3 DVL1	3.22e-06	4	26	2	33496066
Pubmed	Loss of Dishevelleds disrupts planar polarity in ependymal motile cilia and results in hydrocephalus.	DVL3 DVL1	3.22e-06	4	26	2	25043421
Pubmed	Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein.	DVL3 DVL1	3.22e-06	4	26	2	19465938
Pubmed	Phosphorylation of Dishevelled by protein kinase RIPK4 regulates Wnt signaling.	DVL3 DVL1	3.22e-06	4	26	2	23371553
Pubmed	Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation.	DVL3 DVL1	3.22e-06	4	26	2	18772438
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	NKTR PNN RBMX2 KAT6A RSF1	4.17e-06	330	26	5	33301849
Pubmed	A novel Wnt5a-Frizzled4 signaling pathway mediates activity-independent dendrite morphogenesis via the distal PDZ motif of Frizzled 4.	DVL3 DVL1	5.37e-06	5	26	2	25424568
Pubmed	CYLD regulates spindle orientation by stabilizing astral microtubules and promoting dishevelled-NuMA-dynein/dynactin complex formation.	DVL3 DVL1	5.37e-06	5	26	2	24469800
Pubmed	The E3 ubiquitin ligase ITCH negatively regulates canonical Wnt signaling by targeting dishevelled protein.	DVL3 DVL1	5.37e-06	5	26	2	22826439
Pubmed	Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.	DVL3 DVL1	5.37e-06	5	26	2	20227366
Pubmed	DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability.	DVL3 DVL1	5.37e-06	5	26	2	10330181
Pubmed	Malformation of Tear Ducts Underlies the Epiphora and Precocious Eyelid Opening in Prickle 1 Mutant Mice: Genetic Implications for Tear Duct Genesis.	VANGL2 DVL3 DVL1	5.88e-06	47	26	3	33141892
Pubmed	Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling.	VANGL2 DVL3 DVL1P1 DVL1	6.11e-06	161	26	4	36398662
Pubmed	Analysis of PRICKLE1 in human cleft palate and mouse development demonstrates rare and common variants involved in human malformations.	VANGL2 BMP4	8.05e-06	6	26	2	24689077
Pubmed	Deletion of the Dishevelled family of genes disrupts anterior-posterior axis specification and selectively prevents mesoderm differentiation.	DVL3 DVL1	8.05e-06	6	26	2	32579954
Pubmed	Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.	DVL3 DVL1	8.05e-06	6	26	2	34139860
Pubmed	Nuclear factor of activated T cells (NFAT) proteins repress canonical Wnt signaling via its interaction with Dishevelled (Dvl) protein and participate in regulating neural progenitor cell proliferation and differentiation.	DVL3 DVL1	8.05e-06	6	26	2	21880741
Pubmed	SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling.	DVL3 DVL1	8.05e-06	6	26	2	20439735
Pubmed	Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells.	DVL3 DVL1	1.13e-05	7	26	2	10806215
Pubmed	Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity.	VANGL2 RERE	1.13e-05	7	26	2	22510986
Pubmed	Dishevelled proteins regulate cell adhesion in mouse blastocyst and serve to monitor changes in Wnt signaling.	DVL3 DVL1	1.13e-05	7	26	2	17005174
Pubmed	Disheveled mediated planar cell polarity signaling is required in the second heart field lineage for outflow tract morphogenesis.	VANGL2 DVL1	1.13e-05	7	26	2	22841628
Pubmed	All Dact (Dapper/Frodo) scaffold proteins dimerize and exhibit conserved interactions with Vangl, Dvl, and serine/threonine kinases.	VANGL2 DVL1	1.50e-05	8	26	2	21718540
Pubmed	A coated vesicle-associated kinase of 104 kDa (CVAK104) induces lysosomal degradation of frizzled 5 (Fzd5).	DVL1P1 DVL1	1.50e-05	8	26	2	19643732
Pubmed	Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth.	DVL3 DVL1	1.50e-05	8	26	2	15454084
Pubmed	Sequence requirement and subtype specificity in the high-affinity interaction between human frizzled and dishevelled proteins.	DVL3 DVL1	1.50e-05	8	26	2	19388021
Pubmed	G alpha o mediates WNT-JNK signaling through dishevelled 1 and 3, RhoA family members, and MEKK 1 and 4 in mammalian cells.	DVL3 DVL1	1.50e-05	8	26	2	18187455
Pubmed	Regulation of AChR clustering by Dishevelled interacting with MuSK and PAK1.	DVL3 DVL1	1.50e-05	8	26	2	12165471
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MYOF RERE SNAPC4 PNN SCAF8 RBMX2	1.88e-05	774	26	6	15302935
Pubmed	LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6.	DVL3 DVL1	1.93e-05	9	26	2	22899650
Pubmed	RNF43 truncations trap CK1 to drive niche-independent self-renewal in cancer.	DVL3 DVL1	1.93e-05	9	26	2	32965059
Pubmed	Prickle1 stunts limb growth through alteration of cell polarity and gene expression.	VANGL2 BMP4	1.93e-05	9	26	2	23913870
Pubmed	Regulation of the Wnt signaling pathway by disabled-2 (Dab2).	DVL3 DVL1	1.93e-05	9	26	2	12805222
Pubmed	Frizzled 2 and frizzled 7 function redundantly in convergent extension and closure of the ventricular septum and palate: evidence for a network of interacting genes.	VANGL2 DVL3	1.93e-05	9	26	2	23095888
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	DVL3 BMP4 MYOF RSRC2 PNN LUC7L2 DVL1	2.71e-05	1247	26	7	27684187
Pubmed	Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo.	NKTR PNN	2.94e-05	11	26	2	14729963
Pubmed	Protein phosphatase 2Calpha dephosphorylates axin and activates LEF-1-dependent transcription.	DVL3 DVL1	2.94e-05	11	26	2	10644691
Pubmed	Dishevelled 2 is essential for cardiac outflow tract development, somite segmentation and neural tube closure.	DVL3 DVL1	3.53e-05	12	26	2	12421720
Pubmed	Disruption of PCP signaling causes limb morphogenesis and skeletal defects and may underlie Robinow syndrome and brachydactyly type B.	VANGL2 BMP4	3.53e-05	12	26	2	20962035
Pubmed	Mouse prickle1, the homolog of a PCP gene, is essential for epiblast apical-basal polarity.	VANGL2 BMP4	3.53e-05	12	26	2	19706528
Pubmed	RERE deficiency leads to decreased expression of GATA4 and the development of ventricular septal defects.	BMP4 RERE	3.53e-05	12	26	2	30061196
Pubmed	SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response.	NKTR PNN LUC7L2 RBMX2	3.95e-05	259	26	4	30404004
Pubmed	The Hippo pathway regulates Wnt/beta-catenin signaling.	DVL3 DVL1	4.17e-05	13	26	2	20412773
Pubmed	Identification of 2 novel genes developmentally regulated in the mouse aorta-gonad-mesonephros region.	DVL3 DVL1	4.86e-05	14	26	2	12433684
Pubmed	Prickle1 mutation causes planar cell polarity and directional cell migration defects associated with cardiac outflow tract anomalies and other structural birth defects.	VANGL2 DVL1	5.61e-05	15	26	2	26883626
Pubmed	Wnts regulate planar cell polarity via heterotrimeric G protein and PI3K signaling.	VANGL2 DVL3	7.26e-05	17	26	2	32805026
Pubmed	Nucleoredoxin sustains Wnt/β-catenin signaling by retaining a pool of inactive dishevelled protein.	DVL3 DVL1	7.26e-05	17	26	2	20970343
Pubmed	Vangl2 promotes Wnt/planar cell polarity-like signaling by antagonizing Dvl1-mediated feedback inhibition in growth cone guidance.	VANGL2 DVL1	7.26e-05	17	26	2	21316586
Pubmed	GSK-3 signaling in developing cortical neurons is essential for radial migration and dendritic orientation.	DVL3 DVL1	8.16e-05	18	26	2	25073924
Pubmed	The Role of Sorting Nexin 17 in Cardiac Development.	VANGL2 DVL1	9.12e-05	19	26	2	34988124
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	C11orf98 ZNF800 RERE PNN LUC7L2	1.11e-04	655	26	5	35819319
Pubmed	Chato, a KRAB zinc-finger protein, regulates convergent extension in the mouse embryo.	VANGL2 DVL1	1.12e-04	21	26	2	18701545
Pubmed	T-Box transcription factor Tbx20 regulates a genetic program for cranial motor neuron cell body migration.	VANGL2 DVL3	1.12e-04	21	26	2	17119020
Pubmed	Wnt5a-Vangl1/2 signaling regulates the position and direction of lung branching through the cytoskeleton and focal adhesions.	VANGL2 BMP4	1.12e-04	21	26	2	36026468
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	VANGL2 RERE RSRC2 LUC7L2 KAT6A RSF1	1.43e-04	1116	26	6	31753913
Pubmed	Regulation of planar cell polarity by Smurf ubiquitin ligases.	DVL3 DVL1	1.60e-04	25	26	2	19379695
Pubmed	Activation of Wnt signaling reduces ipsilaterally projecting retinal ganglion cells in pigmented retina.	BMP4 DVL1	2.47e-04	31	26	2	30254141
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	DVL3 RERE LUC7L2 DVL1	2.49e-04	418	26	4	34709266
Pubmed	mTOR plays a pivotal role in multiple processes of enamel organ development principally through the mTORC1 pathway and in part via regulating cytoskeleton dynamics.	VANGL2 BMP4	2.97e-04	34	26	2	32866472
Interaction	LUC7L interactions	VANGL2 NKTR PNN LUC7L2 PRM2 KAT6A	5.31e-07	242	26	6	int:LUC7L
Interaction	NKAP interactions	NKTR PNN LUC7L2 RBMX2 KAT6A	6.58e-07	132	26	5	int:NKAP
Interaction	SRPK1 interactions	RSRP1 BMP4 RSRC2 PNN LUC7L2 RBMX2 KAT6A	1.77e-06	477	26	7	int:SRPK1
Interaction	SRPK2 interactions	RSRP1 BMP4 NKTR RSRC2 PNN LUC7L2 RBMX2 KAT6A	2.18e-06	717	26	8	int:SRPK2
Interaction	NUP43 interactions	NKTR RERE PNN LUC7L2 RBMX2 RSF1 DVL1	1.05e-05	625	26	7	int:NUP43
Interaction	RNF151 interactions	DVL3 ZNF800 NKTR PNN	1.78e-05	123	26	4	int:RNF151
Interaction	CSNK2A1 interactions	DVL3 NKTR SNAPC4 PNN LUC7L2 KAT6A RSF1 DVL1	1.81e-05	956	26	8	int:CSNK2A1
Interaction	DHX8 interactions	NKTR RSRC2 PNN LUC7L2 RBMX2	3.16e-05	292	26	5	int:DHX8
Interaction	PNN interactions	VANGL2 NKTR PNN LUC7L2 RBMX2	3.71e-05	302	26	5	int:PNN
Interaction	C1orf35 interactions	DVL3 PNN LUC7L2 RBMX2 KAT6A	3.83e-05	304	26	5	int:C1orf35
Interaction	ANKRD36B interactions	VANGL2 DVL3 SNAPC4	6.21e-05	60	26	3	int:ANKRD36B
Interaction	ZNF593 interactions	LUC7L2 PRM2 KAT6A	6.53e-05	61	26	3	int:ZNF593
Interaction	VANGL2 interactions	VANGL2 DVL3 PNN DVL1	8.77e-05	185	26	4	int:VANGL2
Interaction	CLK2 interactions	RSRP1 NKTR PNN LUC7L2	1.08e-04	195	26	4	int:CLK2
Interaction	JMJD6 interactions	RSRC2 SCAF8 LUC7L2 RBMX2	1.30e-04	205	26	4	int:JMJD6
Interaction	SNRNP40 interactions	NKTR PNN SCAF8 KAT6A RSF1 DVL1	1.31e-04	637	26	6	int:SNRNP40
Interaction	ZRSR2 interactions	DVL3 NKTR LUC7L2	1.31e-04	77	26	3	int:ZRSR2
Interaction	PSME3 interactions	DVL3 C11orf98 RSRP1 SNAPC4 PRM2	1.37e-04	398	26	5	int:PSME3
Interaction	SNIP1 interactions	DVL3 NKTR PNN LUC7L2 RBMX2	1.70e-04	417	26	5	int:SNIP1
Interaction	RNF43 interactions	VANGL2 DVL3 PNN PDZD4 DVL1	1.90e-04	427	26	5	int:RNF43
Interaction	VANGL1 interactions	VANGL2 DVL3 PNN DVL1	2.17e-04	234	26	4	int:VANGL1
Interaction	RPL22 interactions	VANGL2 BMP4 SNAPC4 LUC7L2 KAT6A	2.18e-04	440	26	5	int:RPL22
Interaction	NFKBIL1 interactions	VANGL2 SNAPC4 PNN	2.29e-04	93	26	3	int:NFKBIL1
Interaction	ZBTB2 interactions	NKTR PNN RBMX2 KAT6A RSF1	2.42e-04	450	26	5	int:ZBTB2
Interaction	NUMA1 interactions	DVL3 PNN KAT6A RSF1 DVL1	2.93e-04	469	26	5	int:NUMA1
Interaction	RRP8 interactions	DVL3 ZNF800 RBMX2 KAT6A	3.19e-04	259	26	4	int:RRP8
Interaction	NKD1 interactions	DVL3 DVL1	3.31e-04	21	26	2	int:NKD1
Interaction	BRD3 interactions	VANGL2 RSRC2 PNN LUC7L2 RSF1	3.73e-04	494	26	5	int:BRD3
Interaction	KCNE3 interactions	VANGL2 DVL3 MYOF PNN	5.28e-04	296	26	4	int:KCNE3
Interaction	ISY1 interactions	DVL3 PNN LUC7L2	6.83e-04	135	26	3	int:ISY1
Interaction	EPB41L4A interactions	VANGL2 DVL3 DVL1	7.59e-04	140	26	3	int:EPB41L4A
Interaction	HDHD2 interactions	LUC7L2 DVL1	7.75e-04	32	26	2	int:HDHD2
Cytoband	Ensembl 112 genes in cytogenetic band chr1p36	RSRP1 RERE DRAXIN DVL1	5.53e-04	681	26	4	chr1p36
GeneFamily	Dishevelled segment polarity proteins\|PDZ domain containing	DVL3 DVL1	4.40e-06	4	16	2	505
GeneFamily	PDZ domain containing	DVL3 PDZD4 DVL1	3.01e-04	152	16	3	1220
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	RERE SNAPC4	9.85e-04	53	16	2	532
GeneFamily	PHD finger proteins	KAT6A RSF1	2.81e-03	90	16	2	88
GeneFamily	RNA binding motif containing	SCAF8 RBMX2	1.49e-02	213	16	2	725
Coexpression	GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN	ZNF800 NKTR DRAXIN SCAF8	3.00e-05	190	25	4	M7317
Coexpression	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	DVL3 RERE LUC7L2 KAT6A	3.60e-05	199	25	4	M9964
Coexpression	GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	RSRP1 RSRC2 PNN RSF1	3.60e-05	199	25	4	M3191
Coexpression	TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING	RSRP1 NKTR RSRC2 LUC7L2	4.61e-05	212	25	4	MM3816
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	NKTR RSRC2 PNN RSF1	4.94e-06	197	26	4	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RSRP1 NKTR PNN	8.41e-05	147	26	3	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	RSRP1 NKTR KAT6A	1.12e-04	162	26	3	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DVL3 BMP4 DRAXIN	1.56e-04	181	26	3	4e81ec1580e9acb22c32c465eb46f83d1e9e424e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DVL3 BMP4 DRAXIN	1.56e-04	181	26	3	ad30c01290fb98adbd0caed301a584761212c977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DVL3 BMP4 DRAXIN	1.56e-04	181	26	3	3a3268a4dff8ffcb79e09f46490e138c96f8d916
ToppCell	cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	C11orf98 DRAXIN PDZD4	1.58e-04	182	26	3	8ccffcbae28c374fd4161fb0d4cf2c49fae557f6
ToppCell	facs-Skin-Anagen\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DVL3 MYOF PDZD4	1.77e-04	189	26	3	adbfc723130079b4caf551f66d2aee86fab1903c
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	RSRP1 NKTR PNN	1.85e-04	192	26	3	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	droplet-Pancreas-Endocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSRP1 NKTR LUC7L2	1.85e-04	192	26	3	0dfd1e9896c34aee0f842f8de5d0e3af62a15f68
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSRP1 NKTR LUC7L2	1.88e-04	193	26	3	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSRP1 NKTR LUC7L2	1.88e-04	193	26	3	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	droplet-Pancreas-Endocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSRP1 NKTR LUC7L2	1.91e-04	194	26	3	3a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSRP1 NKTR LUC7L2	1.91e-04	194	26	3	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSRP1 NKTR RERE	1.94e-04	195	26	3	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSRP1 NKTR RERE	1.94e-04	195	26	3	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RSRP1 NKTR PNN	1.97e-04	196	26	3	a9157809122e6fc5783a291522f103bef30943e4
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	NKTR RSRC2 PNN	2.00e-04	197	26	3	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	Healthy_donor\|World / disease group, cell group and cell class (v2)	RSRP1 NKTR PNN	2.03e-04	198	26	3	1ed0b50c9754727a05c27b21f3546bf2e37eef7f
ToppCell	moderate-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	RSRP1 NKTR PNN	2.03e-04	198	26	3	0a868098b1ee4b28b2149ed766acb09e9c0ce14c
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	NKTR RSRC2 PNN	2.03e-04	198	26	3	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NKTR RSRC2 PNN	2.03e-04	198	26	3	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MYOF NKTR PNN	2.06e-04	199	26	3	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	Healthy/Control\|World / Disease group and Cell class	RSRP1 NKTR PNN	2.06e-04	199	26	3	2623c42b3e79e401a485879b52e8bbcbc581544d
ToppCell	healthy_donor\|World / Disease condition, Lineage, Cell class and subclass	RSRP1 NKTR PDZD4	2.09e-04	200	26	3	afd4d5609adaa470e3d880f8be4a4d55e162b3d6
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NKTR RSRC2 PNN	2.09e-04	200	26	3	12f1685ce8f218433068e090c9d839cd5a1910bf
Computational	Neighborhood of DDX5	RSRP1 RSRC2 SCAF8	8.30e-05	63	15	3	GNF2_DDX5
Drug	Niclosamide [50-65-7]; Up 200; 12.2uM; HL60; HG-U133A	RSRP1 RERE SNAPC4 RSRC2 RSF1	8.78e-07	172	24	5	1998_UP
Drug	Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	DVL3 MYOF RERE KAT6A	4.66e-05	193	24	4	3250_UP
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	NKTR SNAPC4 KAT6A RSF1	4.75e-05	194	24	4	4309_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	DVL3 MYOF SNAPC4 PNN	4.85e-05	195	24	4	5590_DN
Drug	Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	BMP4 MYOF RERE KAT6A	4.85e-05	195	24	4	1539_UP
Drug	Dydrogesterone [152-62-5]; Down 200; 12.8uM; PC3; HT_HG-U133A	NKTR RERE SNAPC4 PRM2	4.95e-05	196	24	4	4254_DN
Drug	5-aminosalicylic acid; Down 200; 100uM; MCF7; HG-U133A	RSRP1 RERE SNAPC4 PNN	5.14e-05	198	24	4	124_DN
Drug	Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; MCF7; HT_HG-U133A	DVL3 AEN NKTR RERE	5.14e-05	198	24	4	5609_DN
Drug	Ald1.1-H_000455; Down 200; 10uM; MCF7; HT_HG-U133A	DVL3 NKTR RERE RSF1	5.14e-05	198	24	4	7516_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; MCF7; HG-U133A	AEN SNAPC4 LUC7L2 RBMX2	5.35e-05	200	24	4	417_DN
Drug	Thiram	VANGL2 DVL3 RSRC2 PNN KAT6A	2.03e-04	533	24	5	ctd:D013893
Drug	N-propanoylmannosamine	BMP4 ST6GAL2	6.20e-04	35	24	2	CID000133240
Drug	Digitoxigenin [143-62-4]; Up 200; 10.6uM; HL60; HT_HG-U133A	RSRP1 RSRC2 KAT6A	6.41e-04	162	24	3	1339_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	AEN SCAF8 LUC7L2	6.53e-04	163	24	3	7453_DN
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	RERE RSRC2 KAT6A	6.64e-04	164	24	3	3852_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	MYOF SCAF8 LUC7L2	7.38e-04	170	24	3	3746_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	AEN SCAF8 LUC7L2	7.76e-04	173	24	3	5336_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	MYOF SCAF8 LUC7L2	7.76e-04	173	24	3	4458_DN
Drug	Beta-Escin [11072-93-8]; Up 200; 3.2uM; PC3; HT_HG-U133A	DVL3 RERE SNAPC4	7.89e-04	174	24	3	4544_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	MYOF SCAF8 LUC7L2	7.89e-04	174	24	3	7105_DN
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A	RSRP1 BMP4 RSRC2	7.89e-04	174	24	3	5215_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	MYOF SCAF8 LUC7L2	8.02e-04	175	24	3	6316_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	MYOF SCAF8 LUC7L2	8.02e-04	175	24	3	5935_DN
Drug	Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; PC3; HT_HG-U133A	BMP4 SNAPC4 RSRC2	8.02e-04	175	24	3	4651_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SNAPC4 SCAF8 LUC7L2	8.16e-04	176	24	3	1212_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	MYOF SCAF8 LUC7L2	8.29e-04	177	24	3	7047_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	MYOF SCAF8 LUC7L2	8.70e-04	180	24	3	5981_DN
Drug	Ellipticine [519-23-3]; Down 200; 16.2uM; PC3; HT_HG-U133A	MYOF AEN SCAF8	8.70e-04	180	24	3	5779_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	MYOF SCAF8 LUC7L2	8.84e-04	181	24	3	7077_DN
Drug	Mycophenolic acid [24280-93-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A	DVL3 AEN NKTR	8.84e-04	181	24	3	2857_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	AEN SCAF8 LUC7L2	8.84e-04	181	24	3	7005_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	MYOF SCAF8 LUC7L2	8.99e-04	182	24	3	5802_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	AEN SCAF8 LUC7L2	9.27e-04	184	24	3	6939_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	MYOF SCAF8 LUC7L2	9.42e-04	185	24	3	5882_DN
Drug	cytochalasin B; Down 200; 20.8uM; MCF7; HT_HG-U133A_EA	NKTR SNAPC4 PNN	9.72e-04	187	24	3	1122_DN
Drug	Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; MCF7; HT_HG-U133A	DVL3 MYOF KAT6A	9.72e-04	187	24	3	5023_DN
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	RSRP1 NKTR KAT6A	9.87e-04	188	24	3	4545_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	AEN NKTR GPR22	1.02e-03	190	24	3	2137_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	DVL3 RERE SNAPC4	1.02e-03	190	24	3	4582_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	NKTR RSRC2 KAT6A	1.02e-03	190	24	3	4322_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	MYOF SCAF8 LUC7L2	1.03e-03	191	24	3	7503_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NKTR RERE SNAPC4	1.03e-03	191	24	3	1057_DN
Drug	Gramine [87-52-5]; Up 200; 23uM; MCF7; HT_HG-U133A	MYOF GPR22 KAT6A	1.05e-03	192	24	3	2799_UP
Drug	17-AAG; Down 200; 1uM; HL60; HT_HG-U133A	AEN NKTR GPR22	1.05e-03	192	24	3	2666_DN
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A	RSRP1 NKTR SNAPC4	1.05e-03	192	24	3	4268_DN
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	RSRP1 MYOF RERE	1.05e-03	192	24	3	3753_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA	PNN LUC7L2 RBMX2	1.05e-03	192	24	3	1047_DN
Drug	rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A	BMP4 MYOF SNAPC4	1.06e-03	193	24	3	1233_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A	DVL3 SNAPC4 KAT6A	1.06e-03	193	24	3	5588_DN
Drug	Hycanthone [3105-97-3]; Down 200; 11.2uM; PC3; HT_HG-U133A	MYOF SNAPC4 PRM2	1.06e-03	193	24	3	4630_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	MYOF RERE KAT6A	1.06e-03	193	24	3	3262_UP
Drug	Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	BMP4 MYOF KAT6A	1.08e-03	194	24	3	4149_DN
Drug	Iopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A	BMP4 MYOF KAT6A	1.08e-03	194	24	3	3527_DN
Drug	Nifedipine [21829-25-4]; Up 200; 11.6uM; PC3; HT_HG-U133A	MYOF RERE SNAPC4	1.08e-03	194	24	3	1814_UP
Drug	Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; PC3; HT_HG-U133A	SNAPC4 RBMX2 KAT6A	1.08e-03	194	24	3	4262_DN
Drug	Racecadotril [81110-73-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	MYOF SNAPC4 RBMX2	1.08e-03	194	24	3	5755_DN
Drug	Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A	DVL3 BMP4 SNAPC4	1.08e-03	194	24	3	7354_DN
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	BMP4 RERE KAT6A	1.08e-03	194	24	3	4411_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A	AEN SNAPC4 LUC7L2	1.08e-03	194	24	3	1209_DN
Drug	Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A	MYOF AEN KAT6A	1.08e-03	194	24	3	5047_DN
Drug	Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A	DVL3 MYOF NKTR	1.08e-03	194	24	3	2838_UP
Drug	Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A	BMP4 AEN SNAPC4	1.08e-03	194	24	3	6070_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	MYOF AEN NKTR	1.10e-03	195	24	3	999_DN
Drug	phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA	RSRP1 NKTR PNN	1.10e-03	195	24	3	1138_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NKTR PNN RBMX2	1.10e-03	195	24	3	1080_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; PC3; HT_HG-U133A	MYOF AEN SCAF8	1.10e-03	195	24	3	1214_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; HL60; HT_HG-U133A	RSRP1 AEN RBMX2	1.10e-03	195	24	3	2359_DN
Drug	Tiletamine hydrochloride; Down 200; 15.4uM; HL60; HT_HG-U133A	MYOF AEN SNAPC4	1.10e-03	195	24	3	3137_DN
Drug	AH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A	MYOF RERE SNAPC4	1.10e-03	195	24	3	6903_UP
Drug	5252917; Down 200; 14uM; MCF7; HT_HG-U133A_EA	RSRP1 BMP4 NKTR	1.10e-03	195	24	3	944_DN
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A	MYOF SNAPC4 LUC7L2	1.11e-03	196	24	3	2051_DN
Drug	Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A	MYOF NKTR KAT6A	1.11e-03	196	24	3	4689_DN
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A	MYOF AEN GPR22	1.11e-03	196	24	3	2198_DN
Drug	Betazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A	MYOF SNAPC4 KAT6A	1.11e-03	196	24	3	6344_UP
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	DVL3 MYOF KAT6A	1.11e-03	196	24	3	5409_DN
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A	DVL3 MYOF RERE	1.11e-03	196	24	3	5226_UP
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A	DVL3 MYOF RERE	1.11e-03	196	24	3	2314_DN
Drug	clozapine; Down 200; 10uM; PC3; HT_HG-U133A	BMP4 MYOF SNAPC4	1.11e-03	196	24	3	4453_DN
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	MYOF SNAPC4 KAT6A	1.11e-03	196	24	3	3256_UP
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A	NKTR RERE KAT6A	1.11e-03	196	24	3	3789_DN
Drug	Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; HL60; HT_HG-U133A	AEN RERE GPR22	1.11e-03	196	24	3	2944_DN
Drug	daunorubicin HCl; Up 200; 1uM; PC3; HT_HG-U133A	DVL3 BMP4 KAT6A	1.11e-03	196	24	3	7511_UP
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; MCF7; HT_HG-U133A	MYOF RERE KAT6A	1.11e-03	196	24	3	3259_UP
Drug	PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A	NKTR GPR22 KAT6A	1.11e-03	196	24	3	4291_UP
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A	MYOF NKTR RERE	1.11e-03	196	24	3	2249_DN
Drug	Demecarium bromide [56-94-0]; Up 200; 5.6uM; MCF7; HT_HG-U133A	BMP4 MYOF RERE	1.11e-03	196	24	3	6269_UP
Drug	Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A	MYOF NKTR KAT6A	1.11e-03	196	24	3	3253_UP
Drug	Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A	RERE SNAPC4 PRM2	1.11e-03	196	24	3	6715_UP
Drug	Prostaglandin E1; Up 200; 10uM; MCF7; HT_HG-U133A	DVL3 MYOF NKTR	1.13e-03	197	24	3	6576_UP
Drug	DAPH; Up 200; 10uM; MCF7; HG-U133A	DVL3 NKTR RBMX2	1.13e-03	197	24	3	624_UP
Drug	Sulfathiazole [72-14-0]; Down 200; 15.6uM; PC3; HT_HG-U133A	MYOF NKTR RERE	1.13e-03	197	24	3	4183_DN
Drug	Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	AEN SNAPC4 RBMX2	1.13e-03	197	24	3	4190_DN
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A	BMP4 RERE SNAPC4	1.13e-03	197	24	3	3801_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	BMP4 RERE SNAPC4	1.13e-03	197	24	3	3763_DN
Disease	Robinow Syndrome	DVL3 DVL1	3.18e-06	4	22	2	C0265205
Disease	Robinow Syndrome, Autosomal Dominant	DVL3 DVL1	3.18e-06	4	22	2	C4551476
Disease	DiGeorge syndrome (is_implicated_in)	DVL1P1 DVL1	5.30e-06	5	22	2	DOID:11198 (is_implicated_in)
Disease	neurodegenerative disease (implicated_via_orthology)	DVL3 DVL1P1 DVL1	1.67e-04	145	22	3	DOID:1289 (implicated_via_orthology)
Disease	lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	DVL1P1 DVL1	6.88e-04	52	22	2	EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575
Disease	neutrophil percentage of leukocytes	C11orf98 ZNF800 RERE SNAPC4	9.84e-04	610	22	4	EFO_0007990
Disease	nicotine dependence	DVL1P1 DVL1	1.54e-03	78	22	2	EFO_0003768
Disease	handedness	VANGL2 RSF1	2.82e-03	106	22	2	EFO_0009902
Disease	cataract	BMP4 ZNF800	4.92e-03	141	22	2	MONDO_0005129
Disease	myocardial infarction (biomarker_via_orthology)	DVL1P1 DVL1	6.29e-03	160	22	2	DOID:5844 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
RKHRDRRDRHRSKSR	VANGL2	21	Q9ULK5
LRKRHKRRSRQHQRF	AEN	26	Q8WTP8
SRLMRRHKRRRRKQK	DVL3	211	Q92997
RHKRRRRKQKVSRIE	DVL3	216	Q92997
RRRRAKRSPKHHSQR	BMP4	286	P12644
RDKSHRHKRARRSRE	RBMX2	296	Q9Y388
RKKAFLRHVRRRHRD	FAM156A	86	Q8NDB6
RKLTHLRKRIHRPRR	KIAA0895	6	Q8NCT3
NRDRKHRRSVDRKRR	PNN	641	Q9H307
RKQHLIRAREQRKRR	PDZD4	681	Q76G19
FLHRRRRVRKRKHHN	KAT6A	1016	Q92794
RTRKRSREHKRRRDR	DRAXIN	131	Q8NBI3
RKHLRRLYRRQERHR	C7orf61	166	Q8IZ16
IRKHKRRRRKQRLRQ	DVL1	216	O14640
IRKHKRRRRKQRLRQ	DVL1P1	216	P54792
RAVKRHRERRERQKR	GPR22	296	Q99680
RRGKEIRRVHKRRLS	RSF1	1231	Q96T23
KHRKRSRSRSRERKR	SCAF8	426	Q9UPN6
KNPKRSRSREHRRHR	LUC7L2	266	Q9Y383
RERRHRSRSRERKKS	RSRC2	131	Q7L4I2
LEHERSRRRKHKRRP	NKTR	216	P30414
RRVKKRHRRQRRSHV	ST6GAL2	171	Q96JF0
RRHRRQAVFRRIKTR	RERE	451	Q9P2R6
KSRSRSRRRHQRKYR	RSRP1	61	Q9BUV0
KRRRVLNRERRLRHR	C11orf98	21	E9PRG8
IHRRQHRSCRRRKRR	PRM2	66	P04554
SRRGVRRHIRKVHKK	ZNF800	241	Q2TB10
KKQGLRRRRRRARHS	SNAPC4	501	Q5SXM2
HTHRRRRLVRKRKKD	MYOF	1016	Q9NZM1